Annual General Meeting in Biacore International AB

Annual General Meeting in Biacore International AB Uppsala, Sweden, May 9, 2001 Biacore International AB (Biacore) (SSE: BCOR; Nasdaq: BCOR) today announced that today's Annual General Meeting was attended by 49 shareholders, representing 48 percent of the total number of shares and votes in the Company. The meeting decided that the unrestricted shareholders' equity should be carried forward in its entirety as retained earnings. The meeting reelected the board members, i.e. Mr. Lars-Göran Andrén, Dr Gordon Edge, Mr. Tom Erixon, Dr Ulf Jönsson, Mr. Donald R. Parfet, Mr. Mats Pettersson and Dr. Marc Van Regenmortel. The unions had nominated Mrs. Anna Hansson and Mr. Markku Hämäläinen as their representatives on the board and Mr. Hans Sjöbom and Mr. George Van der Veer as deputies. The meeting decided, in accordance with the board's proposal, that, as part of its incentive program, the Company shall issue debt instruments, to a wholly owned subsidiary, with a total of 300,000 detachable warrants to subscribe for new shares in the Company. The debt instruments of Class A shall be combined with 262,700 detachable warrants of series 2001/2006, and the debt instruments of Class B shall be combined with 37,300 detachable warrants of series 2001/2011. Each warrant gives the holder a right to subscribe for one new share in the Company with a nominal amount of ten Kronor. A warrant of series 2001/2006 expires on May 31 2006 and a warrant of series 2001/2011 expires on May 31 2011. The subscription price shall be equivalent to a price amounting to 100 percent of the most recent average price paid, quoted in the Stockholmsbörsen official list for the Company's shares during the period from 2 May 2001 until 15 May 2001. The increase of the share capital corresponds to a dilution of approximately 3 per cent (app. 6.7 per cent in total with the incentive program introduced in 2000). The stock options shall be issued free of charge to employees within the Biacore Group. No more than 30,000 stock options shall be issued to the executive chairman of the board, no more than 25,000 stock options to the president, no more than 10,000 stock options to the members of the executive group, no more than 4,000 to other key personnel and no more than 500 to other employees. The decision by the meeting was unanimous. This press release contains certain forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, which, by their nature, involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There are a number of factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. Biacore is a global market leader in Surface Plasmon Resonance (SPR) based technology with its own sales operations in the U.S., across Europe, in Japan, Australia and New Zealand. The technology is protected by a strong patent portfolio. Target groups consist primarily of medical and life science research laboratories and pharmaceutical and biotechnology companies all over the world. Biacore focuses on drug discovery as the prime area for future growth. The Company currently has six systems on the market with its BIACORE®3000 system offering specific application in drug discovery processes upstream of high-throughput screening (HTS). A new high-performance system is currently under late- stage development and will focus on applications downstream of HTS. Based in Uppsala, Sweden, the Company is listed on Stockholmsbörsen and Nasdaq in the U.S. In 2000 the Company has sales of SEK 438.8 million and an operating income of SEK 78.0 million. Further information on Biacore can be found on the web: www.biacore.com Address and phone: Biacore International AB Rapsgatan 7, SE-754 50 Uppsala, SWEDEN Phone: +46 (0)18-675700 Fax: +46 (0)18-150111 info@biacore.com ------------------------------------------------------------ This information was brought to you by BIT http://www.bit.se The following files are available for download: http://www.bit.se/bitonline/2001/05/09/20010509BIT01010/bit0001.doc http://www.bit.se/bitonline/2001/05/09/20010509BIT01010/bit0001.pdf